We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Advanced Instruments Acquires Manufacturer of Anaerobic Instruments

By Labmedica staff writers
Posted on 27 Nov 2007
Advanced Instruments, Inc. More...
(Norwood, MA, USA) has acquired Mart Microbiology B.V. (Lichtenwoorde, The Netherlands). The terms of the transaction were not disclosed.

Mart Microbiology manufactures and markets the Anoxomat line of instruments. These systems create custom environments for anaerobic bacteria cultivation, a process that requires oxygen-deprived atmospheres. They are used for the diagnosis of post-operative infection in hospitals and clinics, plus bacterial cultivation in food microbiology laboratories.

Anoxomat provides many advantages over traditional methods of cultivating anaerobes. The system can quickly create a precision anaerobic environment that enables reliable and rapid bacteria cultivation. It uses less lab space than traditional "glove box” cabinets and can provide typical returns on investment in less than one year.

The system rapidly and automatically creates anaerobic, micro-aerophilic, or capnophilic conditions in an anaerobic jar. It uses precise pressure measurements guided by an embedded computer to control the evacuation and refilling of the anaerobic jar. The touch screen display allows the user to simply enter the desired percentages of oxygen and other gases, and to save these ‘recipes' for future reference.

Advanced Instruments has been the U.S. distributor of Anoxomat products for more than six years and has placed many systems at leading American medical centers. In addition, Mart products are sold in other global regions through an established factory-trained dealer network.

"Mart Microbiology is a perfect fit for our company,” said John Coughlin, president and CEO, Advanced Instruments. "It is the clear market leader in this developing technology and compliments our company's market presence globally. The experience gained as Anoxomat's U.S. distributor gives us a high degree of confidence in making this strategic move,” he said.

Advanced Instruments currently operates a facility in The Netherlands and it is anticipated that the operations of Mart Microbiology will be integrated into that facility sometime in the near future.


Related Links:
Advanced Instruments
Mart Microbiology B.V.

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.